| 1 |
35119252 | Effects of Tadalafil on skeletal muscle tissue: exploring interactions and novel mechanisms of action. | 2022 Feb 4 |
2 |
| 2 |
35396013 | Lodenafil. | 2022 |
1 |
| 3 |
33663041 | Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy: A network meta-analysis. | 2021 Feb 26 |
1 |
| 4 |
32604853 | Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation. | 2020 Jun 26 |
4 |
| 5 |
32663396 | Structure of Human Phosphodiesterase 5A1 Complexed with Avanafil Reveals Molecular Basis of Isoform Selectivity and Guidelines for Targeting α-Helix Backbone Oxygen by Halogen Bonding. | 2020 Aug 13 |
1 |
| 6 |
28213937 | Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure. | 2018 Jan |
1 |
| 7 |
29275958 | EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil. | 2018 Mar |
1 |
| 8 |
30029473 | Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF. | 2018 Jul 19 |
2 |
| 9 |
27232892 | Avanafil - a further step to tailoring patient needs and expectations. | 2016 Sep |
2 |
| 10 |
27377089 | A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice. | 2016 Jul 4 |
1 |
| 11 |
27416913 | Avanafil for the treatment of erectile dysfunction. | 2016 Sep |
1 |
| 12 |
27871960 | Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors. | 2016 Jul |
1 |
| 13 |
25801159 | Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5. | 2015 May 1 |
1 |
| 14 |
24589460 | Avanafil for male erectile dysfunction: a systematic review and meta-analysis. | 2014 May-Jun |
2 |
| 15 |
24818838 | Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction. | 2014 May 12 |
2 |
| 16 |
25582903 | Avanafil for the treatment of erectile dysfunction. An updated review. | 2014 Dec |
2 |
| 17 |
23656343 | Phosphodiesterase inhibitors in clinical urology. | 2013 May |
1 |
| 18 |
24259695 | Avanafil for erectile dysfunction. | 2013 Oct |
4 |
| 19 |
26558086 | Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. | 2013 Sep |
1 |
| 20 |
22248153 | A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. | 2012 Apr |
1 |
| 21 |
22384456 | Avanafil for the treatment of erectile dysfunction. | 2012 Jan |
1 |
| 22 |
22448738 | Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial. | 2012 Dec |
5 |
| 23 |
22759639 | Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability. | 2012 Aug |
5 |
| 24 |
22087063 | Future prospects in the treatment of erectile dysfunction: focus on avanafil. | 2011 |
1 |
| 25 |
20939743 | Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction. | 2010 Nov |
2 |
| 26 |
18197727 | Looking to the future for erectile dysfunction therapies. | 2008 |
1 |